We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




New Immunoassay Analyzer Introduced at 2016 AACC Annual Meeting

By LabMedica International staff writers
Posted on 12 Aug 2016
Print article
Image: The Atellica Solution, a highly flexible immunoassay and clinical chemistry analyzer (Photo courtesy of Siemens Healthineers).
Image: The Atellica Solution, a highly flexible immunoassay and clinical chemistry analyzer (Photo courtesy of Siemens Healthineers).
The recently renamed medical instrument manufacturer Siemens Healthineers (Erlangen, Germany) chose the July 31 - August 4, 2016, AACC Annual Meeting & Clinical Lab Expo (Philadelphia, PA, USA) as the venue for introducing its new Atellica Solution automated immunoassay and clinical chemical analyzer system.

In May 2016, Siemens Healthcare changed its name to Healthineers, a name that embodied the company’s pioneering spirit and engineering expertise in the healthcare industry. It is unique and bold name and gives a new identity to the organization and to its employees who serve and inspire healthcare providers worldwide.

One of Healthineers' dynamic new products is the Atellica Solution. This highly flexible immunoassay and clinical chemistry solution features patented bi-directional magnetic sample-transport technology that allows the system to operate 10 faster than conventional conveyors. The platform boasts a multi-camera vision system and intelligent sample routing that allows independent control over every sample from routine assays to STATs.

Atellica Solution, which can handle more than 30 sample container types including pediatric and special containers, can be used as a stand- alone instrument, or it can be scaled up to 10 components with more than 300 customizable configurations. The system supports remote-access monitoring and control, which maximizes instrument uptime, with a broad and expanding assay menu using proven detection technologies.

"We engineered the Atellica Solution based on our customers' needs and extensive research of market trends," said Franz Walt, president of laboratory diagnostics at Siemens Healthineers. "The result is a game-changer that delivers control and simplicity, so our customers can focus on driving better business and clinical outcomes and spend less time managing operations."

The Atellica Solution is currently being evaluated by the Food and Drug Administration and is not yet available in the United States.

Related Links:
Siemens Healthineers
AACC Annual Meeting & Clinical Lab Expo
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.